Skip to content
★ Sign in to follow
RD

Richard D. Pilnik

Board Director
Director
Total declarations
16
Company
1
▲ Purchases (9 ops.)
€357k
▼ Sales (0 ops.)
—

Latest filing published 08 Apr 2025 for DiaMedica Therapeutics Inc., €46k.

Filing timeline

BuySale
Richard D. Pilnik

Insider track record

Disclosed buys
9
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-19.3%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Richard D. Pilnik: trading record in brief

Richard D. Pilnik, listed as board member, appears in our data through filings on DiaMedica Therapeutics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 11 December 2018 to 7 April 2025, the count stands at 16 filings.

On the market, this insider has only ever bought: 9 purchases, €357k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants and 1 option exercise.

In size, the median ticket on the buying side is €23k. 9 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 8 April 2025: an option exercise of €46k, in DiaMedica Therapeutics Inc. The most recent open-market purchase was published on 26 June 2023, 1,232 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Richard D. Pilnik

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations